Skip to main content

Table 4 Severity level of DDIs associated with comedications

From: Prescription patterns of comedications associated with drug-drug interactions risk in HCV-infected patients undergoing direct-acting antiviral treatment: an analysis of an administrative claims database in Japan

 

Overall

SOF/VEL

GLE/PIB

Total

7,338

467

6,871

DDIs: Contraindication (Red)

115

1.6%

0

0.0%

115

1.7%

DDIs: Potential clinically significant interaction (Amber)

2337

31.8%

276

59.1%

2061

30.0%

DDIs: weak interaction (Yellow)

1367

18.6%

1

0.2%

1366

19.9%

No DDIs

3519

48.0%

190

40.7%

3329

48.5%

  1. The denominators for percentage calculation were the total number of cases in each group